Sito in Italia dove è possibile acquistare la consegna acquisto Viagra a buon mercato e di alta qualità in ogni parte del mondo.

Apa in office procedure room 6-23-1

Robert P. Wills, M.D.
Brannon R. Frank, M.D.
John W. Wages, M.D.
Christine M. Anderson, M.D.
Paul H. Le, M.D.
Alan D. Silberberg, M.D.
Laura K. Prewitt-Buchanan, M.D.
Austin, TX 78758 Phone: 512-416-7246 Fax: 512-416-6791 www.austinpainassociates.com APA In-Office Procedure Room Guidelines
PRE-PROCEDURE INSTRUCTIONS
PATIENT INFORMATION:
 For your safety, do NOT eat anything for at least 6 hours prior to the time of your procedure. You may
have water up to 2 hours prior to the time of your procedure. You may also have black coffee (with no
added creamer, half & half or milk of any sort) up to 2 hours before your appointment. If these precautions
are not followed you will not be offered sedation and may need to reschedule.
 Continue all of your usual medications as prescribed unless you are taking blood thinners (such as Coumadin, Plavix, Lovenox) or insulin. You may take your morning medications with a sip of water.  If you are taking blood thinners such as Coumadin, Plavix, Pletal, Pradaxa or Lovenox, ask the
physician who prescribes this medication if they feel it is safe for you to discontinue them before your injection. Below is the number of days required to discontinue each medication prior to your procedure: o If you are taking Coumadin or Pradaxa, you must stop these medication 5 days prior to your
procedure, with approval of the prescribing physician. o If you are taking Plavix or Pletal (Cilostazol), you must stop these medications 7 days prior to your
procedure, with approval of the prescribing physician. o If you are taking Lovenox, you must stop this medication 24 hours prior to your procedure, with
 If you have diabetes, make sure to eat a light meal 6 hours prior to your procedure. o If your procedure is scheduled prior to 12 pm, HOLD your morning insulin dose.
o If your procedure is scheduled after 12pm, take half of your morning insulin dose.
o Bring your insulin with you.
 If your procedure involves sedation you MUST have a driver. We cannot release you to a cab or public transportation. The only exception is Special Transit Services (STS).  Wear comfortable clothing and low-heeled shoes.  Please leave jewelry and other valuables at home.  If you arrive 30 minutes later than your scheduled procedure time your procedure may be delayed or  If you need to cancel your procedure please call 416-7246. PRIOR TO YOUR PROCEDURE:
 You will have an IV started.
 Your doctor may prescribe sedation to help reduce discomfort and anxiety.
 The entire process from checking in to being discharged takes approximately 2 hours.
 Your family may wait for you in the waiting room.
AFTER YOUR PROCEDURE:
 You will remain in the recovery room approximately 20-30 minutes after your procedure.  You may experience side effects from the sedation medications. The nursing staff will go over these with  The office staff will inform you of your next clinic visit prior to your discharge. AFTER DISCHARGE FROM THE FACILITY:
 Do not operate a vehicle or heavy machinery 24 hours after you have received sedation.
 Pain relief may occur immediately after the procedure, but may also take several days. A few days of
soreness after the procedure are normal. Some procedures may take several days to effectively relieve pain.  We suggest applying ice to injection sites for 20 minutes and then removing for 20 minutes. Repeat this cycle of applying ice for the first 24 hours.  Notify the office if you have a fever (body temperature of 101 degrees Fahrenheit or higher).

Source: http://www.austinpainmanagement.com/wp-content/uploads/2012/01/PRE_PROCEDURE_INSTRUCTIONS.pdf

03-5202 dep sprinkles.pdf

This information is intended for U.S. residents only. DEPAKOTE® Sprinkle Capsules DIVALPROEX SODIUM COATED PARTICLES IN CAPSULES BOX WARNING: HEPATOTOXICITY: HEPATIC FAILURE RESULTING IN FATALITIES HAS OCCURRED IN PATIENTS RECEIVING VALPROIC ACID AND ITS DERIVATIVES. EXPERIENCE HAS INDICATED THAT CHILDREN UNDER THE AGE OF TWO YEARS ARE AT A CONSIDERABLY INCREASED RISK OF DEVELOPING FATAL

Microsoft word - c4414129.doc

Sixty-first Session of the General Assembly of the United Nations Request for the inclusion of a supplementary item in the agenda of the sixty-first session Question of the representation and participation of the 23 million people of Taiwan in the United Nations Letter dated XXX from the representatives of XXX to the United Nations addressed to the Secretary-General Upon the

Copyright © 2010-2014 Medicament Inoculation Pdf